CSTF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.859400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.770400E-01
Normal-vs-Stage2
9.333800E-01
Normal-vs-Stage3
2.575200E-01
Normal-vs-Stage4
6.074400E-01
Stage1-vs-Stage2
3.910400E-01
Stage1-vs-Stage3
4.642500E-02
Stage1-vs-Stage4
9.031000E-01
Stage2-vs-Stage3
1.406820E-01
Stage2-vs-Stage4
5.663800E-01
Stage3-vs-Stage4
1.568200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.619400E-01
Normal-vs-AfricanAmerican
8.957400E-01
Normal-vs-Asian
6.936200E-01
Caucasian-vs-AfricanAmerican
7.151800E-01
Caucasian-vs-Asian
3.293200E-01
AfricanAmerican-vs-Asian
6.888000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.193400E-01
Normal-vs-Female
8.302200E-01
Male-vs-Female
7.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.886200E-01
Normal-vs-Age(41-60Yrs)
5.297000E-01
Normal-vs-Age(61-80Yrs)
9.199600E-01
Normal-vs-Age(81-100Yrs)
9.175200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.624200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.147200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.525200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.307590E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.376400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.856600E-01
Normal-vs-Daily Drinker
8.493800E-01
Normal-vs-Weekly Drinker
9.035400E-01
Normal-vs-Occasional Drinker
2.768800E-01
Normal-vs-Social Drinker
7.290600E-01
Non Drinker-vs-Daily Drinker
3.525400E-01
Non Drinker-vs-Weekly Drinker
3.531000E-01
Non Drinker-vs-Occasional Drinker
3.417100E-04
Non Drinker-vs-Social Drinker
5.375900E-02
Daily Drinker-vs-Weekly Drinker
9.162400E-01
Daily Drinker-vs-Occasional Drinker
1.146340E-02
Daily Drinker-vs-Social Drinker
3.507600E-01
Weekly Drinker-vs-Occasional Drinker
3.654400E-02
Weekly Drinker-vs-Social Drinker
4.645600E-01
Occasional Drinker-vs-Social Drinker
1.055020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.270200E-01
Normal-vs-Grade 2
9.357800E-01
Normal-vs-Grade 3
8.829800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.947600E-01
Grade 1-vs-Grade 3
5.447000E-01
Grade 1-vs-Grade 4
9.270200E-01
Grade 2-vs-Grade 3
2.500600E-01
Grade 2-vs-Grade 4
9.357800E-01
Grade 3-vs-Grade 4
8.829800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.934000E-01
Normal-vs-NonDiabetic
8.774000E-01
Diabetic-vs-NonDiabetic
1.152600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.608400E-01
Normal-vs-NoPancreatitis
9.320200E-01
Pancreatitis-vs-NoPancreatitis
4.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.367200E-01
Normal-vs-N1
8.920400E-01
N0-vs-N1
8.367200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.093800E-01
Normal-vs-TP53-NonMutant
7.015000E-01
TP53-Mutant-vs-TP53-NonMutant
4.845600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
